PharmaCyte's focus is on treatments for solid Cancerous tumors and Type 1 Diabetes. PharmaCyte doesn't make chemotherapy drugs. They make them safer, and more effective, with no disabling side effects, resulting in better patient outcomes. For Insulin dependent Diabetes (Type 1 and insulin dependent Type 2). PharmaCyte's therapy will encapsulate live cells which will produce insulin on demand to free patients from taking insulin injections.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.